These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31534898)

  • 1. Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis.
    Hu S; Zhu Y; Xia X; Xu X; Chen F; Miao X; Chen X
    Anal Cell Pathol (Amst); 2019; 2019():3815786. PubMed ID: 31534898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.
    Jiang JW; Chen XM; Chen XH; Zheng SS
    World J Gastroenterol; 2011 Aug; 17(31):3605-13. PubMed ID: 21987607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
    Lu M; Fei Z; Zhang G
    Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 Combined with Oxaliplatin Inhibits the Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells via Downregulating PCNA and Cyclin D1.
    Shan K; Wang Y; Hua H; Qin S; Yang A; Shao J
    Biol Pharm Bull; 2019 Jun; 42(6):900-905. PubMed ID: 30930425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
    Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
    Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
    Lee JY; Jung KH; Morgan MJ; Kang YR; Lee HS; Koo GB; Hong SS; Kwon SW; Kim YS
    Mol Cancer Ther; 2013 Mar; 12(3):274-85. PubMed ID: 23053497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1
    Li X; Tsauo J; Geng C; Zhao H; Lei X; Li X
    Am J Chin Med; 2018; 46(8):1915-1931. PubMed ID: 30525897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
    Huynh H; Ong R; Soo KC
    Angiogenesis; 2012 Mar; 15(1):59-70. PubMed ID: 22187171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
    Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
    Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
    Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells.
    Chen J; Peng H; Ou-Yang X; He X
    Melanoma Res; 2008 Oct; 18(5):322-9. PubMed ID: 18781130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
    Zhang S; Tang D; Zang W; Yin G; Dai J; Sun YU; Yang Z; Hoffman RM; Guo X
    Anticancer Res; 2017 Feb; 37(2):465-473. PubMed ID: 28179291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma.
    Wang B; Xu Q; Zhou C; Lin Y
    Acta Biochim Pol; 2021 Nov; 68(4):711-715. PubMed ID: 34730903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
    Geng L; Fan J; Gao QL; Yu J; Hua BJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis.
    Ren Z; Chen X; Hong L; Zhao X; Cui G; Li A; Liu Y; Zhou L; Sun R; Shen S; Li J; Lou J; Zhou H; Wang J; Xu G; Yu Z; Song Y; Chen X
    Small; 2020 Jan; 16(2):e1905233. PubMed ID: 31814271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the antitumor mechanism of ginsenosides Rg3.
    Liu Z; Liu T; Li W; Li J; Wang C; Zhang K
    Mol Biol Rep; 2021 Mar; 48(3):2639-2652. PubMed ID: 33661439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin.
    Kim DG; Jung KH; Lee DG; Yoon JH; Choi KS; Kwon SW; Shen HM; Morgan MJ; Hong SS; Kim YS
    Oncotarget; 2014 Jun; 5(12):4438-51. PubMed ID: 24970805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.